Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "Market Spotlight: Erectile Dysfunction" report has been added to ResearchAndMarkets.com's offering.
This Market Spotlight report covers the Erectile Dysfunction market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
Key Takeaways
Key Topics Covered
OVERVIEW
KEY TAKEAWAYS
DISEASE BACKGROUND
TREATMENT
Oral therapies
Suppositories and injections
Vacuum erection devices (VEDs)
Surgery
EPIDEMIOLOGY
MARKETED DRUGS
PIPELINE DRUGS
RECENT EVENTS AND ANALYST OPINION
Vitaros for Erectile Dysfunction (February 16, 2018)
KEY UPCOMING EVENTS
KEY REGULATORY EVENTS
Adamis Submits Sublingual Tadalafil, Pre-Filled Naloxone Syringe
PROBABILITY OF SUCCESS
LICENSING AND ASSET ACQUISITION DEALS
Acerus Gains Canadian Rights To Metuchen's Stendra
PARENT PATENTS
REVENUE OPPORTUNITY
CLINICAL TRIAL LANDSCAPE
Sponsors by status
Sponsors by phase
BIBLIOGRAPHY
Prescription information
APPENDIX
LIST OF FIGURES
Figure 1: Trends in prevalent cases of erectile dysfunction, 2017-26
Figure 2: Overview of pipeline drugs for erectile dysfunction in the US
Figure 3: Pipeline drugs for erectile dysfunction, by company
Figure 4: Pipeline drugs for erectile dysfunction, by drug type
Figure 5: Pipeline drugs for erectile dysfunction, by classification
Figure 6: Key upcoming events in erectile dysfunction
Figure 7: Probability of success in the erectile dysfunction pipeline
Figure 8: Licensing and asset acquisition deals in erectile dysfunction, 2014-19
Figure 9: Parent patents in erectile dysfunction
Figure 10: Clinical trials in erectile dysfunction
Figure 11: Top 10 drugs for clinical trials in erectile dysfunction
Figure 12: Top 10 companies for clinical trials in erectile dysfunction
Figure 13: Trial locations in erectile dysfunction
Figure 14: Erectile dysfunction trials status
Figure 15: Erectile dysfunction trials sponsors, by phase
LIST OF TABLES
Table 1: Prevalent cases of erectile dysfunction, 2017-26
Table 2: Marketed drugs for erectile dysfunction
Table 3: Pipeline drugs for erectile dysfunction in the US
Table 4: Vitaros for Erectile Dysfunction (February 16, 2018)
Table 5: Historical global sales, by drug ($m), 2013-17
Table 6: Forecasted global sales, by drug ($m), 2019-23
For more information about this report visit https://www.researchandmarkets.com/r/eigble
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.